Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The drug led to an average weight loss of 70.3 pounds over 80 weeks in patients with obesity, with 45% of patients on 12 mg of the once-weekly injectable retatrutide losing up to 30% of their body weight, the drugmaker, Eli Lilly and Company, said in a news release
Notable anticipated approvals for third quarter 2025 include: First SC version of Keytruda in the oncology setting First treatment for non-relapsing secondary progressive multiple sclerosis An off-the shelf gene therapy for a rare genetic condition caused by human papilloma virus A first-in-class agent for bronchiectasis, a chronic inflammatory lung condition A new mechanism of action for spinal muscular atrophy A hot topic in the drug pipeline that continues to garner significant attention is GLP-1s
Read on for the latest research on how Omadas Enhanced GLP-1 Care Track can drive favorable health outcomes and decrease financial waste
The RickA protein of Rickettsia conorii activates the Arp2/3 complex
US$ 27.63
US$ 20.29
US$ 26.74
US$ 26.65
US$ 25.91
US$ 26.75
US$ 27.73
